2016 season of Lessons Learned kicks off Blog Post

Biocat and the CataloniaBio business association are holding the first session in the 2016 season of Lessons Learned on 31 March at the Barcelona Science Park. Experts and professionals from the health and life sciences sector will participate in a session entitled: ‘Models organitzatius a les bio-empreses i la gestió del canvi: Quines són les claus de l’èxit?’ discussing the doubts that come up in moving forward with projects from the biotechnology and pharmaceutical arenas.

 

Catalan biotech sector to meet in Stockholm Blog Post

The sixteenth edition of the BIO-Europe Spring (BES), the main springtime partnering conference of the sector, takes place this year in Stockholm from 4th to 6th April. The Catalan delegation, coordinated by Biocat once again, will be formed by 24 companies and entities –among which are the companies BioingeniumEsteveIntelligent Pharma and Iproteos, based at the Barcelona Science Park (PCB)–, representing more than a half of the Spanish participation at the event.

Minoryx Therapeutics and Palobiofarma receive the 2016 Biosuccess Award Blog Post

The Catalan Association of Biotechnology Companies (CataloniaBio) has recognized with the Biosuccess Award of the Year two companies associated with the Barcelona Science Park (PCB): Minoryx Therapeutics, which has just finished setting up their lab facilities at PCB, and Palobiofarma, which was based at the Parc from 2010 to 2013. The award giving ceremony was held yesterday at Palau de Pedralbes under his winter networking event CataloniaBio Gala Dinner, which this year coincided with the 10th anniversary and gathered more than 250 entrepreneurs, investors, researchers and professionals from the fields of the life sciences and health. 

 

A study with the participation of CNAG shows that Neanderthals and modern humans crossbred much earlier than was previously thought Blog Post

An international research team has find first genetic evidence of modern human DNA in a Neanderthal individual. The discovery –published in Nature– confirms the interbred between Homo sapiens and Homo neanderthalensis and suggests that it happened 100.000 years ago, before the 65.000 years ago previously documented. This earlier genetic exchange, which may have taken place in the Near East, has not been detected in European Neanderthals. The study, led by the Max Planck German Institute, counts among its authors with researchers of CNAG-CRG located at the Barcelona Science Park (PCB).  

 

The University of Barcelona sets up a crowdfunding platform Blog Post

The University of Barcelona (UB), through the Barcelona Institute of Entrepreneurship (BIE), has launched a crowdfunding platform to promote solidarity or research projects that do not receive public funding. The first call has been announced this month of February in collaboration with Verkami. Three projects will compete to achieve the financial resources that they need. The initiative is part of the strategic plan of the BIE– promoted by the UB and Bosch and Gimpera Foundation (FBG), from its headquarters offices at the PCB–with the aim of making tools and resources available to entrepreneurs within the framework of Group UB.

 

Biotech Aromics obtains the seal ‘Innovative SME’ Blog Post

The Ministry of Economy and Competitiveness recently awarded the biotech Aromics the seal of ‘Pyme Innovadora‘ ( Innovative SME)The company -founded in 2005 and specialized in the application of omic sciences in the research and development of new drugs and diagnostic methods- was part of the first generation of companies that participated in the Bioincubator project at the Barcelona Science Park (PCB).

 

Jordi Naval: “I think both researchers and companies should expand their scope of vision and ask themselves where they are headed” Blog Post

Jordi Naval takes over the management of Fundació Bosch i Gimpera (FBG) with a clear objective: building a climate of trust and interaction among researchers, investors and the productive fabric. A very ambitious challenge that Naval faces with the skill and resolution that his double ‘expertise’ as both, a scientist and entrepreneur, has given him.